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ABSTRACT: The biopharmaceutical classification system (BCS)
is now well established and utilized for the development and
biowaivers of immediate oral dosage forms. The prediction of
BCS class can be carried out using multilabel classification. Unlike
single label classification, multilabel classification methods predict
more than one class label at the same time. This paper compares
two multilabel methods, binary relevance and classifier chain, for
provisional BCS class prediction. Large data sets of permeability
and solubility of drug and drug-like compounds were obtained from
the literature and were used to build models using decision trees.
The separate permeability and solubility models were validated, and
a BCS validation set of 127 compounds where both permeability
and solubility were known was used to compare the two aforementioned multilabel classification methods for provisional BCS
class prediction. Overall, the results indicate that the classifier chain method, which takes into account label interactions,
performed better compared to the binary relevance method. This work offers a comparison of multilabel methods and shows the
potential of the classifier chain multilabel method for improved biological property predictions for use in drug discovery and
development.
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1. INTRODUCTION
Oral absorption is dependent on many physiological, physico-
chemical, and formulation effects. Two of these physicochem-
ical main factors are permeability and solubility, which are
considered the main fundamental properties that govern the
rate and extent of oral absorption. The importance of these
two properties has been emphasized in the biopharmaceutics
classification system (BCS).1 The BCS was developed to classify
drugs into one of four classes based on solubility or dissolution
properties and intestinal permeability (Figure 1). The BCS has
been adopted by many regulatory authorities as a standard for
the justification of biowaivers for costly bioequivalence studies.
Compounds that are eligible for biowaviers under the BCS are
immediate release dosage forms with high permeability and high
solubility (BCS class 1) and are experimentally shown to exhibit
rapid dissolution. In addition, the EMA (2010)2 has extended the
eligibility of biowaviers to include certain class 3 compounds.
Therefore, the BCS is shown to be a vital cost-effective tool of
compound development.1,3
In drug discovery the characterization of preliminary BCS
classification is of great interest. The use of a provisional BCS
class prediction can help guide decision making and formula-
tion of compound development strategies.4−9 In addition, it has
been observed that knowledge of the different BCS classes can
give an indication of the rate limiting steps of absorption as well
as potential metabolic routes and transporter interactions.8,10
There are many classification models in the literature that
predict oral absorption, solubility, or permeability classes in
separate models.11−13 These classification models predict just
one property and assign a compound to one class label out of
two or more mutually exclusive class labels, for example high or
low absorption. This is single label classification. The problem
with this is that in a real life scenario most objects belong to
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Figure 1. Biopharmaceutics classification system (BCS).
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more than one class at the same time. For example a drug
molecule can be highly absorbed but can also have high solubility
or low solubility. The prediction of multiple class labels at the
same time is termed multilabel classification.14−16 Due to the
relationship between solubility and permeability with oral
absorption, a potential multilabel problem exists.
Early research into multilabel modeling has focused on text
categorization,17,18 and now this type of method has expanded
into being utilized in many different fields such as gene function
prediction,19 medical diagnosis,20 and drug discovery.21 There
are two main types of multilabel methods: problem transforma-
tion and algorithm adaption methods. Problem transformation
methods involve transformation of the multilabel data into
single label data to then carry out conventional single label
classification. Therefore, problem transformation methods can
also be termed algorithm independent methods and be used
with any single label classification method. Algorithm adaption
methods involve the adaption of original single label algorithms
to deal with multilabel data directly.14−16
Problem transformation is a more common route for dealing
with multilabel data. There are several different strategies to
transform multilabel data into single label data for analysis.
A common approach is the binary relevance method (Figure 2).
This is where each class label, or property, is separately
predicted. The results are then combined to give the results for
the multilabel problem. In relation to the BCS prediction,
solubility and permeability are predicted separately and then
the predicted BCS is assigned on the basis of the combined
permeability and solubility prediction based on the two
separate labels. This method is simple, and any single label
classification algorithm can be used. A benefit of this method is
that the numbers of compounds in the data sets do not need to
be identical as the properties are modeled separately; therefore
all available data is used. However, one important drawback
of this method is that it fails to take into account label
interactions.14−16
An example of binary relevance multilabel method utilized
in the literature for BCS classification is by Pham-The and
co-workers.6 Although the multilabel method term binary
relevance is not mentioned in this study, it built separate
models for the in silico prediction of solubility or Caco-2 cell
permeability. The results from the models were then combined
to give a provisional BCS prediction.6 A similar study predicts
solubility and rate of metabolism separately to predict
biopharmaceutical drug disposition classification class (BDDCS)10
using the combined predictions.22
Another typical multilabel method in the problem trans-
formation category is called label power set. This is where the
two labels to be predicted are converted into a single label by
combining the labels.14 In the context of the BCS, this method
is basically the prediction of BCS classes directly. Therefore,
rather than a prediction of solubility and permeability a BCS
class is predicted. The only relevant examples in the literature
predict BDDCS class,10,23 instead of predicting BCS class.
In one example the prediction of BDDCS class was carried out
using recursive partitioning (building a single decision tree),
random forest (building a set of decision trees), and support
vector machine.23 Although this method takes into account
interactions between labels, the main problem with this method
is the lack of representation of some of the classes. In other
words some classes may have fewer examples compared to the
rest, and this leads to a poor prediction accuracy for that
underrepresented class.22 In addition, models can only be built
when both labels are known, therefore not utilizing all of the
data available. Therefore, for this work this method was not
utilized due to the drastic reduction of data available for
modeling. Note that it is also possible to predict continuous
values of permeability and solubility, or another approach would
be to classify compounds into multiple categories (low, medium,
high).24 However, these approaches are out of the scope of this
current work since we are engaged in binary classification of
chemicals according to the BCS.
A less well-known multilabel method is classifier chain.16
This method seeks to overcome the drawbacks of binary
classifier by taking into account label interactions. The method
works by first predicting one label, then, using the predicted
label along with any other predictors (molecular descriptors),
models are built in order to predict the second label (Figure 3).
Then the predictions from both labels are combined like binary
relevance for the final BCS prediction. A potential issue with
this method could be the noisy data created from using the
predicted value of the first label as a descriptor to predict the
second label.
One of the problems of this method is deciding which label
to predict first.25 In some cases there may be a definite order of
the labels from a mechanistic point of view, making this choice
obvious. For example, in the case of solubility and permeability
prediction, solubility would be the first label and permeability
would be the second. This is because solubility is a basic
property that can affect permeability of molecules, whereas
permeability is a higher level property. Molecules need to be
dissolved and solubilized first, before they can permeate the
intestinal wall.
Both binary relevance and classifier chain also require an
extra step to convert the single labels into a final label result
Figure 2. How the binary relevance problem transformation method
works for BCS prediction.
Figure 3. Prediction of BCS using the classifier chain multilabel
method.
Molecular Pharmaceutics Article
dx.doi.org/10.1021/mp500457t | Mol. Pharmaceutics 2015, 12, 87−10288
(BCS class assignment). Both have the benefit of utilizing all
available data for modeling without being restricted like the
power set method.
An overview of the methods mentioned can be found in
Table 1. Binary relevance and classifier chain were the methods
utilized in this work.
There are a number of methods in the literature that assign
BCS for drug compounds.26−28 However, these do not offer a
computational prediction of BCS class based on chemical
structure alone using quantitative structure activity relationships
(QSAR). Whereas there are a lot of studies that predict either
permeability or solubility in separate studies, there are few that
utilize multilabel classification. Therefore, the aim of this work is
to compare two multilabel methods for the prediction of BCS.
To our best knowledge there are no other works in the literature
which compare multilabel methods for provisional BCS
prediction suitable for use in drug discovery. Binary relevance
is a simple multilabel method; however, one disadvantage is it
cannot take into account any interactions between the labels.
Based on this, this work introduces the classifier chain multilabel
classification method for application in the pharmaceutics and
drug discovery field: to the best of our knowledge, this is the
first work using classifier chains in the pharmaceutical sciences.
It is anticipated that, by using this method and taking into
account the label interactions, more accurate models can be
produced for provisional BCS prediction. This work shows the
potential of multilabel classification methods, which can be used
for the future prediction of many pharmacokinetic properties in
drug discovery and development.
2. METHODS AND MATERIALS
2.1. Data Sets. 2.1.1. In Vitro Permeability. The
permeability data set to build the initial permeability models
was taken from the published data set of Pham-The et al.,
2013.6 This data set contained apparent permeability values for
1301 compounds from the Caco-2 cell line, measured in the pH
range 6.5−7.4. Apparent permeability (Papp) is the rate of permea-
tion across cell monolayers and is usually measured in cm/s−1.
Upon the removal of duplicates, erroneous compounds, and
compounds with molecular weights greater than 3000, a data set
of 1288 compounds remained for permeability modeling. In
addition, one compound (HBED) was found to have the
incorrect SMILES (simplified molecular-input line-entry system)
code and was corrected. Based on previous work, the benchmark
threshold to define the boundary between high and low
permeability for 80% human intestinal absorption (HIA) was
set at 7.08 × 10−6 cm/s (logPapp of −5.15).29 Therefore, a
compound with in vitro permeability < 7.08 × 10−6 cm/s would
be defined as poorly permeable and a compound with
permeability ≥ 7.08 × 10−6 cm/s would be defined as highly
permeable.29
In addition, in vitro permeability data collected from Caco-2
and MDCK cell lines, measured in the pH range 6.5−7.4, for
127 compounds were compiled from our previously published
data set.29 These 127 compounds were not present in Pham-
The et al.’s published permeability data set; therefore, those
compounds were to act as a BCS validation set for provisional
BCS prediction. This BCS validation set contained 127 com-
pounds where both in vitro permeability and aqueous solubility
were known (Supporting Information S1).
2.1.2. Solubility. Experimental and qualitative aqueous
solubility data were obtained from the previously published
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values (see Supporting Information S2). The majority of these
solubility values were obtained from the AQUASOL dATA-
bASE (6th ed.)30 and Martindale (2009).31 For the 250
qualitative solubility values that were obtained, these were
converted to numerical values based on the principles of Kasim
et al.32 according to Table 2.
From this initial data set of 750 compounds, 127 compounds
whose permeability was known were used for the BCS valida-
tion set. This resulted in a smaller data set of 623 compounds
used to build and validate the resulting solubility models.
In the BCS, the definition of the boundary between high
and low solubility is determined using the dose number (Do =
(Mo/Vo)/S, where Mo is the highest dose strength, Vo is 250 mL,
and S is the aqueous solubility (mg/mL)): compounds with
Do ≤ 1 are classed as highly soluble, and drugs with Do > 1 are
assigned as poorly soluble drugs.1,3 However, in early drug dis-
covery the clinical dose is usually unknown; therefore a suitable
threshold needs to be defined. Additionally, Do is a property of the
drug formulation and not a specific property of the active com-
pound. For this work, a solubility cutoff of 0.2 mg/mL was set.
Hence, any drug with solubility ≥0.2 mg/mL was defined as
highly soluble and drugs with solubility <0.2 mg/mL were classed
as poorly soluble. A value of 0.2 mg/mL was used as, according to
Lipinski et al.,33 this value is the minimum solubility required
to get a projected clinical dose of 1 mg/kg for compounds with
low permeability. This cutoff for solubility has also been used in a
recent work for BCS using MDCK permeability and solubility.5
2.2. Molecular Descriptors. 2D and 3D molecular
descriptors were calculated using TSAR 3D v3.3 (Accelrys
Inc.), MDL QSAR (Accelrys Inc.), MOE (Chemical Computing
Group Inc.) v2012.10, and Advanced Chemistry Development
ACD Laboratories/LogD Suite v12. For molecular descriptors
calculated based on their 3D structure, the 3D structures of the
molecules were first optimized. This was done after removing all
the salts and then assigning atomic partial charges. Molecules
were minimized to their lowest energy conformation using the
AM1 semiempirical method as implemented in MOE software
(version 2012.10). A total of 492 molecular descriptors were
generated and made available for a feature selection procedure
carried out in a data preprocessing phase, before model building.
2.3. Training and Validation Sets. The compounds in
each permeability and solubility data set were sorted based on
either ascending logPapp or logS (mg/mL) separately
(excluding the 127 compounds used for the BCS validation
set). For each individual data set, from each group of five
consecutive compounds, four were assigned to the training set,
and one compound was allocated to the validation set randomly.
By doing this a similar distribution of values in the training and
validation sets was achieved for both data sets. The resulting
compound numbers in the training and validation sets are
shown in Table 3.
The training sets were used to build separate models to predict
permeability and solubility classes. The individual validation sets
for the permeability and solubility data sets were used to measure
the predictive performance of the individual models for the two
types of classes. Lastly, in order to compare the two multilabel
methods for the provisional BCS classification, an additional BCS
validation set containing 127 compounds with known per-
meability and solubility values was used (BCS validation set).
2.4. Feature Selection. Feature selection reduces the
number of molecular descriptors used to describe the property
(class) being modeled, i.e., solubility or permeability. Feature
selection can improve interpretability, improve model accuracy,
and reduce overfitting of resulting models.34,35 Initially, using
the training sets only, molecular descriptors with more than 10
missing values were removed, so that 14 molecular descriptors
were removed from each training set, and this resulted in 478
molecular descriptors available for feature selection. However,
there were still certain molecular descriptors with fewer than 10
missing values in the data set.
Based on previous work we used predictor importance ranking
in random forest to obtain the top 20 molecular descriptors.35
Using only the training set, optimization of the random forest
was carried out based on the plot of misclassification rate vs
the number of trees. The misclassification rate is the number
of misclassified compounds divided by the total number of
compounds. Based on this plot the optimum number of trees
was selected (106 for the solubility, 109 for the permeability).
The maximum number of levels for each tree was set to the
default 10. The software default value of nine was used for
the number of molecular descriptors used in each tree. From the
random forest model, the top 20 molecular descriptors were
selected based on a ranking function called predictor importance
in STATISTICA v 12. For a more detailed description of
the feature selection method, see ref 35. The top 20 molecular
descriptors for each property (solubility and permeability) can be
found in Supporting Information S3.
2.5. Classification and Regression Trees (C&RTs).
STATISTICA v12 (StatSoft Ltd.) software was used for building
each classification model using C&RT analysis. C&RT analysis is
a statistical technique that uses decision trees to solve regression
and classification problems developed by Breinman et al.36
For the binary relevance method, each classi.e. solubility or
permeability variablewas set as the dependent variable and
binary classification was carried out using selected molecular
descriptors as the independent variables to create individual
models for each class label.
For the classifier chain method, initially individual solubility
classification models were built using the top 20 molecular des-
criptors as chosen by feature selection. These models were then
used to predict the solubility class for the whole permeability
data set. The permeability model was then built setting
permeability class as the dependent variable, while the
predicted solubility and the top 20 molecular descriptors pre-
selected for permeability were set as the independent variables.
The preliminary results indicated that predicted solubility class
(acting as a molecular descriptor) would not be used high up in
Table 3. Training and Validation Set Compound Numbers
Used in This Work
type of data set training (n) validation (n) BCS validation (n)
permeability 1026 262 127
solubility 490 133 127
Table 2. Solubility Definitions Adapted from Kasim et al.32
descriptive term (solubility definition) solubility assigned (mg/mL)
very soluble (VS) 1000
freely soluble (FS) 100
soluble (S) 33
sparingly soluble (SPS) 10
slightly soluble (SS) 1
very slightly soluble (VSS) 0.1
practically insoluble (PI) 0.01
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the tree (if at all); therefore predicted solubility was selected
manually as the first molecular descriptor in the C&RT model
for permeability. The rest of the C&RT decision tree was
allowed to be built automatically.
For this work the stopping factors used when growing the
C&RT tree were minimum number of compounds for splitting.
These stopping factors were the default values for the software
and are based on the number of compounds in the data set.
This enables pruning of the tree and prevents overfitting of the
decision tree. For the permeability and solubility data sets,
stopping factors of 25 and 12 respectively were used.
2.5.1. Misclassification Costs for Classification Models.
Misclassification costs are a useful method to overcome the
data set bias of imbalanced class distributions (where one class
value is much more frequent than another) without reducing
data set size.35,37 Even if the data set has a balanced class
distribution, the application of higher misclassification cost for
a specific class can increase the predictive accuracy and reduce
misclassification errors of that specific class.
The solubility and permeability data sets have roughly balanced
class distributions; therefore, misclassification costs can remain as
equal (FP:FN of 1:1, where FP:FN is the ratio of the number of
false positives to the number of false negatives). However, usually
there is an underrepresentation of BCS classes 3 and 4 due to the
low number of poorly permeable compounds and compounds
with both poor permeability and poor solubility. Therefore, in
order to potentially improve the predictive accuracy of these
underrepresented classes, higher misclassification costs can be
applied to reduce false positives (i.e., the number of compounds
in the poor solubility and poor permeability classes which are
wrongly predicted as having high solubility or high permeability),
in order to take into account the lack of compound re-
presentation for these classes when combining the solubility and
permeability predictions. A higher misclassification cost of 1.5 was
applied to the false positive class (FP:FN of 1.5:1) based on the
data distribution of the permeability and solubility data sets.
2.6. Statistical Evaluation of Classification Models.
2.6.1. Single Label Models of Permeability and Solubility.
Specificity (SP), sensitivity (SE), cost normalized misclassifica-
tion index (CNMI), and SP × SE were used to measure the
predictive performance of the classification models. Specificity
is defined as SP = TN/(TN + FP), where TN is the number of
true negatives and FP is the number of false positives. SP is the
fraction of poorly permeable/soluble compounds correctly
classified by the models. Sensitivity (SE) is the ratio of highly
permeable/soluble compounds correctly classified by models and
is defined as SE = TP/(TP + FN), where TP is the number of
true positives and FN is the number of false positives. The overall
predictive performance of a model was measured by multiplying
the specificity and sensitivity (SP × SE). This measure is an
effective way to assess a model’s predictive performance as it takes
into account the effect of class distribution. By contrast,
conventional accuracy measures usually define the ratio of correct
over the total number of predictions and do not consider the class
imbalance of data sets. This SP × SE measure has been used in
previous investigations for oral absorption prediction.35,37 Finally,
to take into account misclassification costs in the models, the cost
normalized misclassification index (CNMI) was calculated.
CNMI can be calculated by eq 1.
= × + ×
× + ×
CNMI
(FP  Cost ) (FN  Cost )
(Neg  Cost ) (Pos  Cost )
FP FN
FP FN (1)
CostFP and CostFN are the misclassification costs assigned for
false positives and false negatives, and Neg and Pos define the
total number of negative and positive observations, respectively.
The calculated CNMI value will be between zero and one, where
zero shows no misclassification errors and as the number of
misclassifications increases the value increases toward 1 (complete
misclassification error). For a more detailed explanation of eq 1,
see ref 36.
2.6.2. Multilabel Models of Provisional BCS Class. The
evaluation of multilabel classification models requires different
measures compared to conventional single label classification
models.14,15 The statistical evaluation of multilabel work can be
difficult as a result can be fully correct, partially correct, or fully
incorrect. Therefore, it is important to have several different
evaluation measures, due to the issue of multiple class labels,
to help select the best model, i.e., the one with the best model
performance over a set of evaluation measures.
For multilabel classification there are two broad types of
evaluation measures. These are label based evaluation measures
and label set evaluation measures.14−16 Label based evaluation
measures are those based on the individual single labels, such as
Hamming loss38 and classification/subset accuracy.17,39 In this
work, the accuracy of the individual four BCS classes was used,
which is essentially the converse of the Hamming loss, in the
sense that the latter is to be minimized, while the individual
accuracy per class is to be maximized. The individual class
accuracy for each class was calculated by dividing the correct
number of predictions for compounds of that class by the total
number of compounds of that class, resulting in four accuracy
measures for the individual four BCS classes. Additionally, for
this work the SP × SE accuracy measure of the individual
permeability and solubility labels was calculated.
Label set evaluation measures are based on the prediction of
all labels together. Therefore, measures of this type can be very
harsh, as, if there is not a perfect prediction of both labels
for a compound, that prediction will be considered completely
wrong, even if one of the two labels was correctly predicted.
Examples of label set evaluation measures are micro-averaging
and macro-averaging.40 The label set evaluation measures used
in this work are based on macro-averaging.40 Macro-averaging
is the average, by compound, of all the accuracies for the
different BCS classes. To calculate the overall accuracy, the
number of correct predictions (regardless of class) was divided
by the total number of compounds. However, this value could
be biased and not give an accuracy measure which would show
the predictive accuracy of all four classes. Therefore, in addition
the geometric mean of all four individual predictive accuracy
measures for the BCS classes was calculated. The geometric
mean is measured by multiplying all four BCS class accuracy
measures and taking the fourth route of this product. The
benefit of this measure is that it will not be biased toward the
distribution or predictive accuracy of any individual BCS class.
In other words, if a model can predict three out of four classes
with high accuracy but is unable to predict accurately for one
class, the geometric mean accuracy will be low.
3. RESULTS
3.1. Permeability and Solubility C&RT Models. In this
work we are investigating the use of two multilabel classification
methods to predict provisional BCS class using permeability
and solubility from the literature and published data sets.
Separate models of permeability and solubility were built
using training sets of 1026 and 490 compounds respectively,
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using the top 20 molecular descriptors selected by the random
forest based feature selection method. The predictions from
the solubility and permeability models were then combined
to give a provisional BCS class for a BCS validation set of
127 compounds. All the C&RT decision trees that produced
the results reported in Tables 4 and 5 can be found in
Supporting Information S4. In Tables 4 and 5, the best models
are those that have the highest SP, SE, and SP × SE and the
lowest CNMI. These have been highlighted in bold for the
training and validation sets in these tables. First, the two
solubility models whose results are shown in Table 4 are
models with equal and higher misclassification costs applied
to reduce false positives: models 1 and 2, respectively. The
compound numbers in training and validation sets for solubility
and permeability for Tables 4 and 5 are lower than the original
numbers in Table 3. This is because for certain compounds
molecular descriptors were unable to be calculated and
therefore were unable to be classified in the terminal nodes.
Therefore, the compound numbers in Tables 4 and 5 represent
the compound numbers classified by the models.
Both solubility models from Table 4 can be considered the
best depending on the intended use and purpose of the model.
Model 1 has the highest sensitivity for the training set and
validation set as well as overall accuracy for the validation set,
whereas model 2, as expected, has the highest SP for the
training and validation set due to the application of higher
misclassification costs to reduce false positives. Therefore, if the
aim of the model is to predict poorly soluble compounds,
model 2 would be the best model; but model 1 would be the
best to use if the aim was to predict highly soluble compounds.
Model 1 may be considered as the best C&RT model in this
work (shown in Figure 4), since for the validation set there is
more of a balanced prediction for poorly and highly soluble
compounds (higher SP × SE). Both solubility models were
then used to predict solubility for compounds in the
permeability data set, which was in turn used as an additional
descriptor (independent variable or feature) for building the
permeability model: this process implements the classifier chain
approach for multilabel classification, discussed earlier.
The statistical parameters of the permeability models pro-
duced in this work are shown in Table 5. Initially permeability
models were built using only the top 20 molecular descriptors
selected by the random forest based feature selection method
(models 1 and 4). Next, permeability models were built
using the predicted solubility either from the solubility model 1
or from solubility model 2 in Table 4 in addition to the top
20 molecular descriptors as the independent variables. Again
models were also built with equal (models 1−3) or higher
misclassification costs (models 4−6) applied to reduce false
positives (FP:FN 1.5:1).
Based on the validation set, the best permeability model to
choose would be model 2. This permeability model was built
using the predicted solubility from model 1 in Table 4, and
equal misclassification costs applied. This model achieved the
highest overall accuracy (SP × SE) and sensitivity for the
validation set of 0.519 and 0.742, respectively. In addition, it
also had the second highest SP × SE and SE for the training set
and the lowest CNMI for the training and validation sets, when
comparing the other models with equal misclassification costs
applied (models 1−3).
Table 5 shows that when equal misclassification costs are
applied (models 1−3), a higher overall accuracy model (based
on the validation set) is produced using predicted solubility
(from solubility model 1 in Table 4) as a molecular descriptor
to predict permeability class. Although model 3 has a lower
overall accuracy, its specificity is much higher, and this could
be due to the influence of the solubility model included in
the permeability model (solubility model 2). In other words,
Table 5. Results of C&RT Analysis for the Classification of Permeability (with and without Predicted Solubility Incorporated in
the Model)
model misclassification cost ratio (FP:FN) solubility Model included set na SP × SE SE SP CNMI
1 1:1 none t 1016 0.653 0.847 0.771 0.192
v 261 0.503 0.727 0.692 0.291
2 1 t 1016 0.655 0.841 0.778 0.191
v 261 0.519 0.742 0.699 0.280
3 2 t 1016 0.638 0.761 0.838 0.200
v 261 0.482 0.641 0.752 0.303
4 1.5:1 none t 1016 0.659 0.807 0.817 0.188
v 261 0.484 0.664 0.729 0.298
5 1 t 1016 0.630 0.716 0.880 0.185
v 261 0.489 0.586 0.835 0.265
6 2 t 1016 0.625 0.706 0.884 0.187
v 261 0.489 0.586 0.835 0.265
aNote that the numbers of compounds used in the analysis are lower than the available compounds due to missing descriptor values for some
chemicals.
Table 4. Results of C&RT Analysis for the Classification of Solubility
model misclassification cost ratio (FP:FN) set na SP × SE SE SP CNMI
1 1:1 t 485 0.621 0.784 0.792 0.212
v 128 0.578 0.795 0.727 0.234
2 1.5:1 t 485 0.638 0.706 0.903 0.178
v 128 0.538 0.658 0.818 0.243
aNote that the numbers of compounds used in the analysis are lower than the available compounds due to missing descriptor values for some
chemicals.
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improving the prediction of poorly soluble compounds resulted
in higher prediction accuracy for poorly permeable compounds
according to Table 5.
When higher misclassification costs are applied to false
positives in the permeability models, models 5 and 6 have
better overall accuracy (SE × SP) for the validation set and the
lowest CNMI for the training set was obtained by model 5.
Overall, the application of higher misclassification costs to
reduce false positives resulted in the increased specificity and
lower misclassification errors (CNMI), but overall accuracy is
lower in models 4−6 in comparison with models 1−3. As
expected, model 6, which included predicted solubility from
model 2 in Table 4, had a higher specificity due to the higher
misclassification costs originally applied to the solubility model,
which have been utilized to improve prediction accuracy for
poorly permeable compounds.
3.2. Interpretation of Selected Solubility and Perme-
ability Models. Solubility classification models were devel-
oped using the top 20 molecular descriptors. In addition,
permeability models were developed using either the top 20
molecular descriptors (selected using random forest) or the
top 20 molecular descriptors plus predicted solubility from
solubility models built in this work. It must be noted that
although the top 20 molecular descriptors were given as input to
the algorithm that builds the C&RT tree, not all the molecular
descriptors were used to build the decision trees, since the
C&RT also performs an additional “embedded” feature selec-
tion process, adding to the tree only attributes deemed relevant
for class prediction by the algorithm.35 Furthermore, some
molecular descriptors can be used more than once in a C&RT
tree, as discussed below. Figure 4 is the selected solubility model
1 based on the classification decision tree.
The first split variable in Figure 4 is ACDLogD(5.5), the
logarithm of the apparent distribution coefficient between
octanol and water at pH 5.5, a measure of hydrophobicity. This
descriptor as well as logP has been used in many publications
for modeling of different properties such as oral absorption,11,37
permeability,12,41 and solubility models.13,42 The use of logD at
pH 5.5, despite solubility being measured at pH 7.4, is justified
based on the fact that this descriptor indicates not only the
effect of lipophilicity but also the effect of acid/base property of
the compounds. For example, an acidic and a basic compound
of similar logP values will have different logD at this pH
depending on their percentage of ionization. At pH 5.5, the
Figure 4. Tree graph for C&RT analysis for the prediction of solubility class with equal misclassification costs (model 1 in Table 4).
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acidic compound will be mainly un-ionized and hence its
logD(5.5) will be close to its logP value, whereas the basic
compound will be highly ionized, and therefore it will have
a lower logD(5.5) than its logP value. In relation to solubility,
highly lipophilic compounds can give rise to poor solubility, as
indicated by Figure 4. In this model compounds are poorly
soluble if they have a LogD(5.5) > 1.16, and examples of poorly
soluble drugs in this node are diclofenac and ibuprofen:
both are BCS class II compounds (poorly soluble but highly
permeable).43,44 There is no further splitting of the highly
lipophilic, poorly soluble compounds, indicating that this
molecular descriptor is useful to define poor solubility
(<0.2 mg/mL) for this tree. The relatively less lipophilic
compounds (LogD(5.5) ≤ 1.16) are further characterized
into high/low solubility using LogD(5.5); this time a lower
threshold of 0.06 is used. In this case both nodes 4 and 5 are
associated with high solubility; however, compounds that have
higher LogD(5.5) (but lower than 1.16) are poorly soluble only
if they have a vertex distance equality index (VDistEq) > 3.66.
Computed from a distance matrix, VDistEq is mainly related to
the size and shape (branching) of a molecule.45 Compounds
with larger VDistEq tend to be larger and in most cases (less
branched) linear molecules.
For compounds with lower LogD(5.5) than 0.06, the next
molecular descriptor to split the tree is the partial charge
descriptor, PEOE_VSA_FPOS. Using PEOE partial charge
calculation,46 PEOE_VSA_FPOS is the sum of the van der
Waals surface area of positively charged atoms divided by the
total surface area of the molecule.45 According to Figure 4,
those compounds with a PEOE_VSA_FPOS > 0.67 will be
highly soluble, indicating that those with more positive partial
charges (an indication of higher polarity and ionization) will be
highly soluble. This is in agreement with the literature, where
more polar molecules tend to be more soluble in water.47
However, as depicted by this tree, node 6 (containing less
polar compounds with PEOE_VSA_FPOS ≤ 0.67) is not pure
at all and needs more splitting with other molecular descriptors;
in this case, LogD(7.4) is used twice in the tree for these
compounds. In Figure 4 compounds will be classed as poorly
water-soluble if −0.51 < LogD(7.4) ≤ −0.16. It must be noted
here that all these compounds have a LogD(5.5) below 1.155,
as a result of division of node 2 and therefore they are hydro-
philic enough to be classed as water-soluble. Examples of these
poorly water-soluble compounds in node 14 are rofecoxib48
and pindolol.49 Overall, from the solubility model, the main
molecular descriptors used to classify solubility are those
related to lipophilicity, ionization, polarity, size, and shape,
which is in accordance with the literature.47,50,51
The best permeability model selected was model 2 in
Table 5. Due to the size of the tree, in order to facilitate its
interpretation the tree has been split into two trees (Figures 5
and 6). Figure 5 shows the half of the permeability decision
tree that is built for those compounds predicted as poorly
soluble by the solubility model 1 in Table 4. Figure 6 shows
half of the C&RT tree for permeability built for those
compounds predicted as highly soluble from the same solubility
model. It must be noted that the trees in Figures 5 and 6 were
originally one tree, and the combined version, as well as all the
other C&RT models presented in this work, is in Supporting
Information S4.
Comparing Figures 5 and 6, it is noted that there is a slightly
larger number of poorly soluble compounds (Figure 5) than
highly water-soluble compounds (Figure 6) in the permeability
data set, and those poorly soluble compounds are mainly highly
permeable (Figure 5) and vice versa. The first split of the tree
in Figure 5 is using the vsurf_W2 molecular descriptor as
calculated by MOE.52 Vsurf and related molecular descriptors
are Volsurf descriptors described by Crucciani et al. (2000)53
that describe the size, shape, polarity, and hydrophobicity
and the balance between these properties on molecules.
More specifically, vsurf_W descriptors describe the volume of
hydrophilic regions of a molecule, calculated at certain
interaction energy levels. In this case vsurf_W2, calculated at
energy level 0.5 kcal/mol, accounts for the polarizability and
dispersion forces in the hydrophilic regions of the molecules.52
According to this tree, poorly soluble compounds in Figure 5
will be classified as highly permeable so long as they have
small hydrophilic volume (node 2). Compounds with larger
hydrophilic volumes in nodes 3 have been divided further
according to logD(6.5). In this case, the general trend is that
less lipophilic compounds (logD(6.5) ≤ 2.10) will be mostly
poorly permeable (node 4), which matches previous observa-
tions in Caco-2 and other in vitro permeability cell lines.29,54
For those less lipophilic compounds (logD(6.5) ≤ 2.10), the
descriptor vsurf_Wp3 is used to discriminate between
compounds with small polar volume (vsurf_Wp3 ≤ 103.8)
which are highly permeable, and compounds with large polar
volume of the molecule (node 7). Compounds will be classified
as poorly permeable due to their large polar volume unless
they have smaller volume (vsurf_W2 ≤ 987), but a polar
surface area (PSA) greater than 127.7 (node 13). Polar surface
area (PSA) is a common molecular descriptor used in oral
absorption models as well as permeability models.11 PSA is the
area of the van der Waals surface that arises from oxygen and
nitrogen atoms or hydrogen atoms bound to these atoms.55
PSA has been cited to have a negative effect on oral absorption
and hence permeability; this was also observed in previous
works using oral absorption data set.11,29,35,37 However, this is
not what is presented in Figure 5 for the permeability data set.
The maximum PSA in this list of compounds (159 Å) is still
moderate in comparison with the rest of the data set. On closer
inspection, the vast majority of these highly permeable com-
pounds contain a sulfonamide or thaizole group. The polarity
measure of these sulfur-containing functional groups using
PSA seems to not correlate with the expected reduced
absorption of polar compounds. Examples of these highly
permeable compounds with large PSA values are glipizide and
two oxazolidinones, antimicrobial agents PNU-182945 and
PNU-183981.
For highly lipophilic compounds (logD(6.5) > 2.1) the next
descriptor used to discriminate between high and low
permeability is the relative negative partial charge descriptor
calculated by PEOE (RPC−). This molecular descriptor is
calculated by dividing the smallest negative charge by the sum
of (most negative) charges on the whole molecule. Therefore,
a higher number of hydrogen bond acceptors such as oxygen
atoms in the molecules leads to lower values of RPC−. In this
instance, compounds with a lower relative negative partial
charge (≤0.09) are poorly permeable. Compounds with a higher
RPC− are mainly highly permeable but can be split further by
the molecular descriptor, GCUT_ PEOE_0. GCUT descriptors
are calculated from the eigenvalues of a modified graph distance
matrix with the diagonal using in this case charges calculated
from PEOE partial charges. A minority of compounds with a
lower GCUT-PEOE_0 than −0.86 have been classed as highly
absorbed. These are structurally large and complex molecules
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with many rings and branches, mostly belonging to nucleotide
based antivirals. Due to similarity of these compounds to natural
metabolites, it is likely that they may have the possibility of
being transported by carrier proteins.
Compounds with a higher GCUT_ PEOE_0 are also classified
as highly permeable unless they have a vsurf_HL2 > 0.086 or if,
despite a smaller vsurf_HL2, they have GCUT_PEOE_0 ≤
−0.856. Vsurf_HL2 describes the hydrophilic−lipophilic balance,
which is the calculated ratio between the hydrophilic regions
measured at 4 kcal/mol and the hydrophobic regions measured
at 0.8 kcal/mol.52 According to the tree in Figure 5, compounds
are predicted as poorly permeable if they have a higher ratio of
hydrophilic to lipophilic effect, and examples include bromoc-
riptine and lansoprazole.
Figure 6 is the permeability model for compounds predicted
as highly soluble according to solubility model 1. In this figure
the same top molecular descriptor as in Figure 5 is selected to
split the compounds into high/low permeability in node 1.
Compounds with vsurf_W2 values greater than 734.2, i.e., larger
hydrophilic volume, are more likely to be poorly permeable
according to this tree. This is unless they have a higher lipo-
philicity (logD(6.5) > 0.01) and lower polar volume, according
to vsurf_Wp2 ≤ 530.8. On the other side of the tree, a majority
of compounds with relatively small hydrophilic volume are
highly permeable unless they are relatively hydrophilic at pH 5.5
(LogD(5.5) ≤ −0.66) and have a PSA higher than 52.4. In this
instance, this PSA threshold is similar to the threshold of 60 Å
used for recent permeability modeling of Caco-2 permeability.41
Based on Figures 5 and 6, it is interesting to note that hydrophilic
volume of a molecule is a better measure of permeability than the
most widely known parameter, partition coefficient. For instance,
in Figure 6, node 2, it can be seen that a good fraction of com-
pounds with lower LogD(5.5) than −0.66 are highly permeable
given that the polar surface area is not too large (≤52.3).
3.3. Provisional BCS Class Prediction in a BCS
Validation Set Using Multilabel Methods. The perme-
ability and solubility models created previously were used to
predict the BCS of a BCS validation set of 127 compounds with
known values for both properties collected from the literature
(BCS validation set). Different combinations of permeability
and solubility models were tried in order to see what effect this
would have on the overall results. Table 6 shows the results
from the different combinations of the permeability and
solubility models presented in Tables 4 and 5. For example,
in Table 6, model 1 is the combination of the solubility model 1
(Table 4) and permeability model 1 (Table 5).
Recall, the multilabel method binary relevance (BR) involves
the prediction of permeability and solubility separately
Figure 5. Tree graph for C&RT analysis (part of model 2 in Table 5) for the prediction of permeability class for predicted poorly soluble
compounds from solubility model 1 (shown in Figure 4).
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(models 1, 2, 7, 8 in Table 6), however it fails to take into
account the relationship between these interrelated properties;
whereas the classifier chain (CC) method, which uses a
predicted solubility alongside structural molecular descriptors
to help predict permeability, takes into account the label
interactions (models 3−6, 9−12 in Table 6). In Table 6, the
overall accuracy (SP × SE) of the permeability and solubility
models for the BCS validation set has also been included.
Table 6. Results of the Provisional BCS Classification of a BCS Validation Set (n = 127) To Compare the Binary Relevance and
Classifier Chain Multilabel Methods




















1 BRd 1 1 0.525 0.565 0.606 0.000 0.566 0.725 0.692 0.000
2 2 0.551 0.591 0.496 0.509 0.725 0.653 0.250
3 CCe 2 1 0.641 0.565 0.630 0.523 0.585 0.700 0.731 0.250
4 2 0.551 0.606 0.590 0.528 0.700 0.654 0.500
5 CCe 3 1 0.642 0.565 0.598 0.508 0.528 0.625 0.806 0.250
6 2 0.551 0.575 0.574 0.453 0.625 0.769 0.500
7 BRd 4 1 0.480 0.565 0.543 0.000 0.453 0.675 0.692 0.000
8 2 0.551 0.528 0.456 0.415 0.675 0.615 0.250
9 CCe 5 1 0.581 0.565 0.559 0.472 0.604 0.450 0.731 0.250
10 2 0.551 0.543 0.563 0.547 0.450 0.654 0.625
11 CCe 6 1 0.587 0.565 0.559 0.481 0.528 0.500 0.808 0.250
12 2 0.551 0.528 0.537 0.434 0.500 0.500 0.500
aOverall accuracy, calculated as correct number of predictions divided by total number of predictions. bGeometric mean, multiplication of all
accuracy predictions of classes 1−4 and taking the fourth root of this product. cClass average, number of correct class predictions divided by total
number of the specific class. dBR, binary relevance. eCC, classifier chain.
Figure 6. Tree graph for C&RT analysis (part of model 2 in Table 5) for the prediction of permeability class with equal misclassification costs for
predicted highly soluble compounds from solubility model 1 (show in Figure 4).
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In addition, the overall accuracy and geometric mean have been
calculated alongside the individual class accuracies in order to
help with interpretation.
From Table 6, based on the overall accuracy, i.e., the highest
percentage of correct predictions, the best model to choose
would be model 3. This model had an overall accuracy
0.630 (80/127) and was created combining the solubility
model 1 and permeability model 2 (with incorporated predicted
solubility). Although this model has the highest number of
correct predictions, it has a poorer predictive accuracy for
class 4. Therefore, using the geometric mean, which gives an
average overall accuracy of all four classes, the best model would
be model 4. This model was created combining the solubility
model 2 and permeability model 2 (with incorporated predicted
solubility). The difference between models 3 and 4 in Table 6 is
the solubility model used with permeability model 2 to put
compounds into BCS classes. Solubility model 1 from Table 4 is
with equal misclassification costs, and solubility model 2 is with
higher misclassification costs to reduce false positives. Different
combinations of the permeability and solubility models result in
the different models having the best accuracy for all four classes.
It is difficult to pick the best model based on the individual
accuracies of the four classes. However, for overall accuracy the
best model to choose would be either model 3 or model 4.
Models 1−6 were all derived from permeability models using
equal misclassification costs applied, whereas models 7−12
were derived from permeability models with higher mis-
classification costs applied to reduce false positives. Overall the
application of higher misclassification costs to false positives
in the permeability models (models 7−12) has led to lower
overall accuracy and geometric mean accuracy; however, it
has also led to the highest class accuracy for class 3 (model 11)
and class 4 (model 10), due to better prediction of the low
permeability compounds as expected.
In order to compare the models built by the two multilabel
methods, first models 1 and 2 in Table 6 can be compared with
models 3−6. Models 1 and 2 were built by the binary relevance
method, whereas models 3−6 were built by the classifier chain
multilabel method. Overall, based on the geometric mean the
classifier chain method obtained higher predictive ability across
all classes. The only exception is that although models 5 and 6
have a higher geometric mean, they have a slightly lower overall
accuracy compared with the binary relevance models 1 and 2.
The superiority of the classifier chain method can also be seen
from the permeability accuracy, which was higher for the
models built by the classifier chain method, indicating that
incorporating predicted solubility into models results in higher
predictive accuracy for permeability. These patterns are also
seen when comparing models 7−12, where higher misclassifi-
cation costs have been applied to reduce false positives for the
permeability models.
4. DISCUSSION
This work has explored attempts to build permeability and
solubility models to computationally predict a provisional BCS
for chemicals in drug discovery by comparing two multilabel
classification methods. The predictions can be very useful in
early drug development and can streamline formulation and
chemical optimization strategies. In addition, the BCS
predictions can give insight into the mechanistic absorption
properties of drugs, such as rate limiting steps like transporter
effects or dissolution limiting solubility.
This work has involved multilabel classification of in vitro
permeability and aqueous solubility to provisionally predict
BCS classes for new chemical entities (NCEs) for early stage
drug discovery. In order to compare the two multilabel
methods, individual permeability and solubility models were
built and validated. Initially, permeability and solubility models
were built using the top 20 molecular descriptors as selected via
random forest based feature selection. Our previous study
shows improved prediction accuracy when a preprocessing
feature selection is performed prior to C&RT analysis.35 In
addition, permeability models were also built utilizing the
predicted solubility alongside the selected molecular descriptors
to predict permeability class. The use of higher misclassification
costs for false positives was also investigated to help improve
class prediction of the poorly permeable and poorly soluble
classes. Using a BCS validation set with known solubility and
in vitro permeability, the predictions of the permeability and
solubility models were combined and compared to the
observed experimental BCS class. In this way, we compared
two multilabel methods using the BCS validation set. Binary
relevance involves the combination of separate, independently
built solubility and permeability models; however this does not
take into account the interactions between these two labels.
In order to overcome this, we compared this method to the
multilabel method classifier chain. This method, in relation
to this work, involved the incorporation of predicted solubility
to build and predict permeability class, and in doing so this
method takes into account the relationship between these pro-
perties. Therefore, we are exploring the idea that the classifier
chain method can help improve permeability class prediction
and in turn provisional BCS class prediction.
4.1. Individual Permeability and Solubility Models.
Both permeability and solubility are important properties in
drug discovery. However, both these properties individually are
complex and can be difficult to model. Lack of high quality data
sets for drug-like compounds can contribute to the difficulty
in predictions. BCS class prediction can overcome variable per-
meability and solubility data by predicting compounds’ classes
rather than specific values as a first initial drug screen. However,
suitable thresholds for discriminating between high and low
permeability/solubility must be selected.
Permeability is the rate of drug absorption through the Caco-2
cell line and is highly correlated with intestinal absorption.29
Similar to intestinal absorption, there are many factors affecting
and influencing permeability. According to the results of this
study using the top 20 molecular descriptors from feature sel-
ection, permeability classes can be predicted with good accuracy.
On the whole it is easier to predict the high permeability class
than it is to predict the poor permeability class when equal
misclassification costs were applied on a data set with balanced
class distribution (higher sensitivity than specificity values in
Table 5). The same pattern emerges in relation to solubility,
where according to this work better predictive accuracy is
obtained for highly soluble compounds when using equal
misclassification costs (Table 4). Solubility is also another
complex parameter to predict with many complex interlinking
factors.56,47
When equal misclassification costs have been applied, using
predicted solubility as a molecular descriptor alongside the
other molecular descriptors to build permeability models
caused two things: models had better overall accuracy and
better accuracy for poorly permeable compounds in com-
parison with the model not incorporating predicted solubility
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(see Table 5). Therefore, the inclusion of predicted solubility in
this way increased the predictive accuracy of the poor
permeability class. When higher misclassification costs were
applied to improve the prediction of poorly permeable
compounds, the specificity of permeability models also
increased upon incorporating predicted solubility. Therefore,
inclusion of predicted solubility into permeability models has
resulted in better models or those that can predict poor
permeability class better. This follows on from previous
research whereby incorporating experimental permeability and
experimental and predicted solubility into oral absorption
models results in higher predictive accuracy.29 When higher
misclassification costs were applied to reduce false positives for
the permeability models, overall lower predictive accuracy was
observed. This could be due to the balanced nature of the data
set, containing roughly 50:50 high:low permeability com-
pounds.
4.2. Comparison of Molecular Descriptors. It is difficult
to directly compare different permeability and solubility models
used in the literature; however the molecular descriptor subsets
used in the models can be compared. The top 20 molecular
descriptors selected by random forest using predictor
importance can be found in Supporting Information S3. In
addition, the top descriptors chosen from the pool of 20, by the
C&RT analysis for the two properties, can also be compared to
see if there are similarities and/or differences, and this can be
related back to the property in question. The top molecular
descriptors selected by the solubility and permeability (C&RT)
models are shown in Tables 7 and 8 respectively. The top
molecular descriptors are counted by how many models they
appear in; also noted in Table 7 is if the molecular descriptor
occurs more than once in the same decision tree. For Table 7, the
molecular descriptors from solubility models 1 and 2 (Table 4)
were used to show the top solubility molecular descriptors. For
Table 8, permeability models 1 and 4 and models 2, 3, 5, and 6
(Table 5) were used to show the top molecular descriptors for
the binary relevance and classifier chain methods, respectively.
For the solubility models 1 and 2 the top molecular descriptor
(Table 7) picked by C&RT analysis was LogD(5.5). Other
studies have identified lipophilicity descriptors related to
LogD(5.5) and LogD(7.4), such as logP, as important for the
prediction of solubility.42,57 The next most frequently picked
molecular descriptor is VDistEq, related to the size and shape of
the molecule. Larger molecules in drugs and drug-like molecules
tend to have higher lipophilicity47 and additionally require
higher energy to create a cavity in the solvent and solvate
(solvation limiting solubility).58 Additionally the size and shape
of a molecule can result in a rigidity that can cause high crystal
lattice energy resulting in poor solubility (solid-state limiting
solubility)47,58 Finally those descriptors related to polarity and
hydrogen bonding are also important for solubility predic-
tion.47,59 Overall, molecular descriptors related to lipophilicity,
size, shape, polarity ,and hydrogen bonding are all important for
solubility of drug compounds as they relate to the crystal lattice
energy, solvent cavity formation energy, and solvation energy, all
important factors for solubility of drug compounds.47,59,60
The top molecular descriptors for the permeability models
in this work picked by the resulting C&RT analysis can be
roughly grouped into five groups: lipophilicity/hydrophobicity
Table 7. Top Molecular Descriptors Selected by C&RT for
the Prediction of Solubility Class (Models 1 and 2 in Table 4)





lipophilicity LogD(5.5) 4a 1, 2
LogD(7.4) 3a 1, 2
size/shape VDistEq 3a 1, 2
BCUT_PEOE_0 1 2
polarity/polarization BCUT_SLOGP_2 1 2
PEOE_VSA_FPOS 1 1
PEOE_VSA_POL 1 2
hydrogen bonding MaxHp 1 2
aOccurred more than once in a single tree model.
Table 8. Top Molecular Descriptors Selected by C&RT for the Prediction of Permeability Class for the Binary Relevance
(Models 1 and 4, Table 5) and Classifier Chain Permeability Models (Models 2, 3, 5, and 6, Table 5)
BRa permeability models CCb permeability models
type of descriptor descriptor no. of C&RT models model (from Table 5) no. of C&RT models model (from Table 5)
lipophilicity/hydrophobicity LogD(6.5) 3c 1, 4 6c 2, 3, 5, 6
LogD(5.5) 1 1 3 2, 3, 6
LogD(10) 3 3, 5, 6
LogD(7.4) 2 1, 4
vsurf_HL1 2 1, 4
vsurf_HL2 4 2, 3, 5, 6
vsurf_CW4 1 1
size of hydrophilic/polar regions vsurf_Wp3 2 1, 4 7c 2, 3, 6
vsurf_W2 1 1 7c 2, 3, 5, 6
vsurf_W3 1 4 2 5, 6
vsurf_Wp2 1 4 2 2, 5
PEOE_RPC− 1 4 4 2, 3, 5, 6
PSA 2c 2
size/shape xv2 2c 4
GCUT_PEOE_0 3c 1, 4 8c 2, 3, 5, 6
chi1_C 2 1, 4
bascity FIBpH6.5 2c 4
hydrogen bonding vsurf_HB1 5c 1, 4 3c 5
aBR: binary relevance. bCC: classifier chain. cOccurred more than once in a single tree model.
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parameters, those describing the size of the hydrophilic or
polar molecular regions, basicity, hydrogen bonding, and finally
size/shape parameters (Table 8). Overall, there are 25 cases of
lipophilicity/hydrophobicity parameters used in the perme-
ability models and 30 cases of parameters describing the size of
the hydrophilic or polar regions of the molecule. These two
make up 69% of permeability related features. There are only
two instances of the basicity parameters, eight cases of hydrogen
bond donor effect, and 15 cases of molecular descriptors related
to size and/or shape utilized in the permeability models.
The importance of hydrophilic or polar size of the molecule has
been seen in previous literature. In particular, polar surface area
has been cited to be important for permeability classification
between low, medium, and high permeability, and is a popular
molecular descriptor used in our models.41 Molecular des-
criptors related to hydrogen bonding are also popular in relation
to permeability61 as well as oral absorption. More specifically
hydrogen bonding is one of the descriptors used in the widely
accepted filter for identifying poorly absorbed compounds,
Lipinski’s rule of five.62 Molecular descriptors important for
permeability such as those related to lipophilicity, size/shape,
polarity, and hydrogen bonding are also important for the
prediction of oral absorption.11,35,37
4.3. Comparison with Related Literature. There are few
studies to our knowledge which use QSAR models to predict
BCS class. However, there are many individual studies that
predict either permeability or solubility. A related work has
been published recently by Pham-The et al. (2013),6 which is
different from this study in terms of the methods, parameters
used, and property thresholds.
As a solubility measure, Pham-The et al. used dose number
(Do) defined as the ratio of drug concentration following
a given dose in the stomach of 250 mL volume to the saturated
solubility. One of the problems with using Do for a provisional
prediction is that Do is a property of the drug formulation and
not a specific property of the active compound. Therefore, the
maximum dose can depend on many things such as formulation
type, toxicity, and drug target affinity, or even different doses
of drug may be used to treat different disease severity or
even different disease states.22 In terms of future predictions,
maximum dose will be needed from the literature in order to
calculate Do. The advantage of our models described here is
that they do not need any experimental values such as the drug
dose for future predictions.
They also used a permeability threshold of 16 × 10−6 cm/s,
based on the permeability of metoprolol, a highly absorbed
drug. This threshold is over double the threshold that was
objectively selected and statistically validated using the
correlation between oral absorption and in vitro permeability
in previous studies.29 The individual permeability and solubility
models developed by Pham-The et al. using a data set of
322 compounds achieved good overall accuracy for the training
and validation sets (>75%). Due to the different data sets and
validation and training sets, the accuracy of the models cannot
be directly compared. We have used larger data sets for model
development that cover a large chemical space. In addition,
the different thresholds used lead to different classification
problems, each resulting in different levels of difficulty for
classification of each property.
Pham-The et al. (2013) validated the models by using first
an external validation set containing 57 compounds from the
WHO (World Health Organization) list of essential medicines.
Unfortunately, in this validation set there was no experimental
Caco-2 permeability data to validate the permeability pre-
diction; furthermore over half of these compounds are assigned
into more than one class, which is potentially inconclusive.
Our work involved validation sets to validate permeability and
solubility models and in addition a BCS validation set where
both permeability and solubility were known, in order to
validate BCS prediction.
There are studies in the literature that predict BDDCS class
(biopharmaceutics drug disposition classification system)10
instead of BCS class. The BDDCS classifies compounds into
one of the four BDDCS classes based on the rate of meta-
bolism, instead of permeability used in the BCS, and solubility
(using dose number). There appears to be a correlation
between BCS and BDDCS classes, but only for passively
absorbed compounds.22 With the growing number of
compounds being identified as undergoing carrier mediated
absorption, the comparison of BCS and BDDCS models could
be complicated.
4.4. Comparison of BCS Class Assignments with the
Literature. The BCS validation set of 127 compounds
contained both in vitro permeability and aqueous solubility
collected from the literature. Based on the literature data, an
observed BCS class was assigned to these compounds using
our thresholds for permeability and solubility. Searching the
literature, we found reported BCS classes for 71 of the 127
compounds in the validation set. From these 71, 10 compounds
were cited in the literature to belong to more than one class
and 16 were cited to belong to a different class from what we
had assigned them based on our solubility and permeability
thresholds. Different assignments of BCS class to compounds
in the literature have also been shown in other studies.63 On
closer inspection of these 16 compounds, the main differences
between our assigned BCS class and the literature-assigned
BCS class are the effect of maximum dose and pH which have
not been considered in our work. In addition there are in vitro−
in vivo differences due to varying levels of transporter
expression in cell lines and gastrointestinal tract. As a result,
some compounds that are poorly soluble and poorly permeable
or highly permeable but poorly soluble in vitro may not
necessarily be poorly absorbed in vivo. Examples include
cinacalcet (class IV), which is poorly soluble and poorly
permeable but is absorbed >80%, and dapsone (class II), which
is poorly soluble but has a % HIA of 90%. The BCS valida-
tion set with the experimentally (in vitro) assigned and
literature assigned compounds can be found in Supporting
Information S1. Concerning the 10 compounds cited as
belonging to more than one class, it is interesting to see how
the best models (those with the best overall accuracy and
geometric accuracy, i.e., models 3 and 4 in Table 6) predicted
these compounds, as their prediction may give more evidence to
the assignment of these compounds to that class. For example
based on our experimental data, ethosuximide is classified as
belonging to class I, however the WHO guidelines state that the
classification of this compound could be either class I or class III
due to insufficient data on permeability. The models 3 and 4
from Table 6 both predict that this compound is class I, and this
is supported by a % HIA of 93%. For the rest of the compounds,
the majority are predicted into either one of the cited classes by
models 3 and 4.
Using model 4 from Table 6, it is interesting to see which
class was assigned to the compounds in the BCS validation set.
This can help understand the error rates associated with the
model and the tendency of the model in relation to BCS class
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prediction. This confusion matrix comparing predicted versus
observed BCS classes is shown in Table 9.
Type I and type II errors were calculated for the values
reported in Table 9. According to Khandelwal et al.,23 type I
errors (false positive errors) represent those compounds that
either are predicted class I when in fact they are observed to be
BCS classes II−IV or are predicted class II or III but are
actually class IV compounds. Therefore, the predicted class is
biopharmaceutically more favorable than the observed actual
class. Type II errors (false negative errors) represent those
compounds that either are predicted as class IV but were
observed to be BCS classes I−III or are predicted as class II or
III but were observed to be class I. In other words, the
predicted class is biopharmaceutically less favorable than the
true class. The % of type I errors was 11.8%, and the % of type
II errors was 25.9%. The results from a similar study by Pharm-
The et al. (2013)6 calculated type I and type errors II of 10.6%
and 14.6% respectively, for their entire data set (training and
validation set) of 322 compounds.
It has been proposed that for BCS class prediction type II
errors should be kept as low as possible.6 This is quite obvious
given that BCS class is used for the decision making regarding
biopharmaceutical experimentations required for oral dosage
forms. Additionally, it might be more desirable to have good
precision of class I compounds, rather than good accuracy, as
these compounds are prioritized for biowaivers.3 This principle
of focusing on precision rather than accuracy may be
appropriate for class III compounds too, due to the increasing
evidence for the suitability of class III compounds for bio-
waivers.64 As seen in Table 9, both of the precision measures
for classes I and III were higher than the respective accuracy
measures. Based on this, it is interesting to see that although
class III is not the most popular represented class in the BCS
validation set compared with classes I and II, it still has high
class accuracy and precision.
It is important to state that the main difficulty for the models
in this work was encountered in predicting class IV compounds.
This was not entirely unexpected, since although the
permeability and solubility data sets had balanced class
distributions, the combination of these resulted in an under-
representation of class IV. This may not be a major concern for
industry; however, from a prediction point of view, not
considering the predictive accuracy of all classes can result in a
higher number of misclassifications, which could prove costly
for industry.23 This could be resolved by balancing all four BCS
classes; however this can drastically reduce the number of
compounds and potentially the models’ ability to predict new
compounds. Our work has utilized all data available and applied
misclassification costs to attempt to overcome the BCS class
imbalance. However, the poor prediction may not be due to the
poor representation of classes and could be also a result of self-
association in water, as cited in other research.22,65
5. CONCLUSION
The in silico prediction of a provisional BCS class is a
challenging task. One of the challenging aspects of BCS class
predictions is the potential effect of solubility on permeability
prediction. Separate models of permeability and solubility fail
to take into account the interactions between the class labels,
and modeling each label separately reduces the generalization
for new compounds. It is well-known in the literature that poor
solubility can give rise to poor and variable absorption.
Therefore, permeability prediction should include and so take
into account the effects of solubility. Hence, using predicted
solubility in permeability models alongside structural molecular
descriptors, as performed in this work using the classifier
chain multilabel classification method, avoids the disadvantage
of other modeling methods for BCS prediction, like binary
relevance multilabel classification.
This work has shown that the classifier chain multilabel
method can greatly influence permeability models and hence
provisional BCS using C&RT analysis. The use of predicted
solubility as a descriptor to build and predict permeability,
using the classifier chain method, has been shown to improve
a permeability model’s predictive accuracy and in turn final
provisional BCS prediction. The molecular descriptors used by
both solubility and permeability models relate to lipophilicity,
hydrogen bonding, polarity, size, and shape; however their
relationship with these properties is usually inversely related.
The benefit of the binary relevance and classifier chain
methods over algorithm adaption methods is the utilization of
large data sets for permeability and solubility. There was no
restriction to the data set just because of missing values,
as separate models for permeability and solubility were built
based on the available data for each property. One limitation
with this type of protocol is the lack of generalization for the
poorly represented class IV compounds. However, this can be
improved slightly with the application of higher misclassifica-
tion costs. The literature reveals a lack of multilabel
classification methods for provisional prediction of BCS class
suitable for a drug discovery scenario. Therefore, according to
our results, the classifier chain method can be used successfully
to improve the prediction of permeability class using predicted
solubility.
Future extensions to this work would be to utilize more
types of multilabel classification methods to perform consensus
prediction similar to those in the literature,6 however the
method must be able to include and use predicted solubility
with the highest weighting in the permeability model.
Table 9. Confusion Matrix of Model 4 from Table 6 for the Prediction of BCS Classes for the Validation Seta
predicted class 1 predicted class 2 predicted class 3 predicted class 4 total accuracy (%)
obsd class 1 28 15** 6** 4** 53 52.8
obsd class 2 7* 28 1 4** 40 70.0
obsd class 3 4* 1 17 4** 26 65.4
obsd class 4 1* 2* 1* 4 8 50.0
total compds 40 46 25 16
precision (%) 70.0 60.9 68.0 25.0
aPrecision (%) is calculated for each class by adding the number of compounds in the column for that class and dividing by the total number of
compounds (column total) for that class. Accuracy (%) is calculated by adding the number of compounds for each class in the row for that class and
divided by the total number of compounds (row total) for that class. *Type I errors. **Type II errors.
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In conclusion, this work has highlighted the potential benefit
of using the classifier chain multilabel method, to predict
provisional BCS class prediction for drug discovery.
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QSPR Approaches in ADME Profiling: A Case Study on Caco-2
Permeability. Mol. Inf. 2013, 32 (5−6), 459−479.
(42) Duchowicz, P. R.; Talevi, A.; Bruno-Blanch, L. E.; Castro, E. A.
New QSPR study for the prediction of aqueous solubility of drug-like
compounds. Bioorg. Med. Chem. 2008, 16 (17), 7944−7955.
(43) Chuasuwan, B.; Binjesoh, V.; Polli, J.; Zhang, H.; Amidon, G.;
Junginger, H.; Midha, K.; Shah, V.; Stavchansky, S.; Dressman, J.
Biowaiver monographs for immediate release solid oral dosage forms:
Diclofenac sodium and diclofenac potassium. J. Pharm. Sci. 2009, 98
(4), 1206−1219.
(44) Potthast, H.; Dressman, J.; Junginger, H.; Midha, K.; Oeser, H.;
Shah, V.; Vogelpoel, H.; Barends, D. Biowaiver monographs for
immediate release solid oral dosage forms: Ibuprofen. J. Pharm. Sci.
2005, 94 (10), 2121−2131.
(45) MOE. QuaSAR-Descriptor help file [Online] Available: http://
www.chemcomp.com/journal/descr.htm [Accessed 14 Jan 2014].
2014.
(46) Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital
electronegativitya rapid access to atomic charges. Tetrahedron 1980,
36 (22), 3219−3228.
(47) Ghafourian, T.; Bozorgi, A. H. A. Estimation of drug solubility
in water, PEG 400 and their binary mixtures using the molecular
structures of solutes. Eur. J. Pharm. Sci. 2010, 40 (5), 430−440.
(48) Davies, N. M.; Teng, X. W.; Skjodt, N. M. Pharmacokinetics of
rofecoxib. Clin. Pharmacokinet. 2003, 42 (6), 545−556.
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